The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women

B. M. Hoenderboom; A. A. M. van Oeffelen; B. H. B. van Benthem; J. E. A. M. van Bergen; N. H. T. M. Dukers-Muijrers; H. M. Gotz; C. J. P. A. Hoebe; A. A. Hogewoning; F. R. M. van der Klis; D. van Baarle; J. A. Land; M. A. B. van der Sande; M. G. van Veen; F. de Vries; S. A. Morre; I. V. F. van den Broek

doi:10.1186/s12879-017-2376-y

The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women

B. M. Hoenderboom^*, A. A. M. van Oeffelen, B. H. B. van Benthem, J. E. A. M. van Bergen, N. H. T. M. Dukers-Muijrers, H. M. Gotz, C. J. P. A. Hoebe, A. A. Hogewoning, F. R. M. van der Klis, D. van Baarle, J. A. Land, M. A. B. van der Sande, M. G. van Veen, F. de Vries, S. A. Morre, I. V. F. van den Broek

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

11 Citations (Web of Science)

Original language	English
Article number	264
Number of pages	9
Journal	BMC Infectious Diseases
Volume	17
DOIs	https://doi.org/10.1186/s12879-017-2376-y
Publication status	Published - 11 Apr 2017

Keywords

Chlamydia trachomatis
Pelvic inflammatory disease
Tubal factor subfertility
Ectopic pregnancy
Host genetic biomarkers
Serology
The Netherlands
PELVIC-INFLAMMATORY-DISEASE
SCREENING-PROGRAMS
COST-EFFECTIVENESS
SUBFERTILE WOMEN
CONTROLLED-TRIAL
TUBAL PATHOLOGY
SUSCEPTIBILITY
IMPLEMENTATION
PROGRESSION
PREVALENCE

Access to Document

10.1186/s12879-017-2376-y

Cite this

Hoenderboom, B. M., van Oeffelen, A. A. M., van Benthem, B. H. B., van Bergen, J. E. A. M., Dukers-Muijrers, N. H. T. M., Gotz, H. M., Hoebe, C. J. P. A., Hogewoning, A. A., van der Klis, F. R. M., van Baarle, D., Land, J. A., van der Sande, M. A. B., van Veen, M. G., de Vries, F., Morre, S. A., & van den Broek, I. V. F. (2017). The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women. BMC Infectious Diseases, 17, [264]. https://doi.org/10.1186/s12879-017-2376-y

Hoenderboom, B. M. ; van Oeffelen, A. A. M. ; van Benthem, B. H. B. ; van Bergen, J. E. A. M. ; Dukers-Muijrers, N. H. T. M. ; Gotz, H. M. ; Hoebe, C. J. P. A. ; Hogewoning, A. A. ; van der Klis, F. R. M. ; van Baarle, D. ; Land, J. A. ; van der Sande, M. A. B. ; van Veen, M. G. ; de Vries, F. ; Morre, S. A. ; van den Broek, I. V. F. / The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women. In: BMC Infectious Diseases. 2017 ; Vol. 17.

@article{a7ee65ea5c1d47f08a957cefe329636b,

title = "The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women",

keywords = "Chlamydia trachomatis, Pelvic inflammatory disease, Tubal factor subfertility, Ectopic pregnancy, Host genetic biomarkers, Serology, The Netherlands, PELVIC-INFLAMMATORY-DISEASE, SCREENING-PROGRAMS, COST-EFFECTIVENESS, SUBFERTILE WOMEN, CONTROLLED-TRIAL, TUBAL PATHOLOGY, SUSCEPTIBILITY, IMPLEMENTATION, PROGRESSION, PREVALENCE",

author = "Hoenderboom, {B. M.} and {van Oeffelen}, {A. A. M.} and {van Benthem}, {B. H. B.} and {van Bergen}, {J. E. A. M.} and Dukers-Muijrers, {N. H. T. M.} and Gotz, {H. M.} and Hoebe, {C. J. P. A.} and Hogewoning, {A. A.} and {van der Klis}, {F. R. M.} and {van Baarle}, D. and Land, {J. A.} and {van der Sande}, {M. A. B.} and {van Veen}, {M. G.} and {de Vries}, F. and Morre, {S. A.} and {van den Broek}, {I. V. F.}",

year = "2017",

month = apr,

day = "11",

doi = "10.1186/s12879-017-2376-y",

language = "English",

volume = "17",

journal = "BMC Infectious Diseases",

issn = "1471-2334",

publisher = "BioMed Central Ltd",

}

Hoenderboom, BM, van Oeffelen, AAM, van Benthem, BHB, van Bergen, JEAM, Dukers-Muijrers, NHTM, Gotz, HM, Hoebe, CJPA, Hogewoning, AA, van der Klis, FRM, van Baarle, D, Land, JA, van der Sande, MAB, van Veen, MG, de Vries, F , Morre, SA & van den Broek, IVF 2017, 'The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women', BMC Infectious Diseases, vol. 17, 264. https://doi.org/10.1186/s12879-017-2376-y

The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women. / Hoenderboom, B. M.; van Oeffelen, A. A. M.; van Benthem, B. H. B.; van Bergen, J. E. A. M.; Dukers-Muijrers, N. H. T. M.; Gotz, H. M.; Hoebe, C. J. P. A.; Hogewoning, A. A.; van der Klis, F. R. M.; van Baarle, D.; Land, J. A.; van der Sande, M. A. B.; van Veen, M. G.; de Vries, F.; Morre, S. A.; van den Broek, I. V. F.

In: BMC Infectious Diseases, Vol. 17, 264, 11.04.2017.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women

AU - Hoenderboom, B. M.

AU - van Oeffelen, A. A. M.

AU - van Benthem, B. H. B.

AU - van Bergen, J. E. A. M.

AU - Dukers-Muijrers, N. H. T. M.

AU - Gotz, H. M.

AU - Hoebe, C. J. P. A.

AU - Hogewoning, A. A.

AU - van der Klis, F. R. M.

AU - van Baarle, D.

AU - Land, J. A.

AU - van der Sande, M. A. B.

AU - van Veen, M. G.

AU - de Vries, F.

AU - Morre, S. A.

AU - van den Broek, I. V. F.

PY - 2017/4/11

Y1 - 2017/4/11

KW - Chlamydia trachomatis

KW - Pelvic inflammatory disease

KW - Tubal factor subfertility

KW - Ectopic pregnancy

KW - Host genetic biomarkers

KW - Serology

KW - The Netherlands

KW - PELVIC-INFLAMMATORY-DISEASE

KW - SCREENING-PROGRAMS

KW - COST-EFFECTIVENESS

KW - SUBFERTILE WOMEN

KW - CONTROLLED-TRIAL

KW - TUBAL PATHOLOGY

KW - SUSCEPTIBILITY

KW - IMPLEMENTATION

KW - PROGRESSION

KW - PREVALENCE

U2 - 10.1186/s12879-017-2376-y

DO - 10.1186/s12879-017-2376-y

M3 - Article

C2 - 28399813

VL - 17

JO - BMC Infectious Diseases

JF - BMC Infectious Diseases

SN - 1471-2334

M1 - 264

ER -